Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years old or older at the time of joining, and who are enrolled in the SJLIFE study (a long-term follow-up study at St. Jude Children's Research Hospital).
- Survivors who were treated for childhood acute lymphoblastic leukemia (ALL), a type of blood cancer diagnosed during childhood.
- People (survivors or comparison group participants) who have lower than average muscle mass, as measured by a specific body composition score (a lean mass z-score of -0.5 or below).
- Survivors who are able and willing to give their written agreement to take part in the trial.
Who may not be able to join:
- Survivors who received radiation treatment to the head (cranial radiation) as part of their cancer treatment.
- People (survivors or comparison group participants) who have implanted medical devices or metal in their body that could interfere with MRI or MRS scans (confirm with trial site).
- People (survivors or comparison group participants) who are currently pregnant.
- People (survivors or comparison group participants) who are taking blood-thinning medications, such as aspirin, apixaban, coumadin, edoxaban, or rivaroxaban.
- People (survivors or comparison group participants) who weigh more than 300 pounds.
- People (survivors or comparison group participants) who have a known allergy to local anaesthetics such as lidocaine or bupivacaine.
- People (survivors or comparison group participants) who are unable to lie flat on their back for 90 minutes or more.
- People (survivors or comparison group participants) who have a current history of nerve damage affecting movement in the arms or legs (peripheral motor neuropathy).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Puneet Bagga, PhD, St. Jude Children's Research Hospital
Phone: 888-226-4343
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To explore feasibility of MRI/MRS to measure OXPHOS capacity; To explore feasibility of 31P-MRS to measure OXPHOS capacity; To explore feasibility of 1H-MRS to measure OXPHOS capacity; To explore feasibility of CrCEST MRI to measure OXPHOS capacity; To explore feasibility of Fat Fraction MRI to measure OXPHOS capacity; To explore feasibility of Muscle Ultrasound to measure OXPHOS capacity; To explore feasibility of Muscle Biopsy to measure OXPHOS capacity; To explore feasibility of mtDNA-CN to measure OXPHOS capacity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.